2024 Edwards Lifesciences First Half Operating and Financial Review-SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Medical Devices Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
- Latest organizational and management developments
- Acquisitions and divestitures
- Marketing tactics
- Financial results
- Strengths and weaknesses
- Strategic directions
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-?-vis their major competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.
More Publications
2023 World Blood Typing, Grouping and Infectious Disease NAT Screening Market-92 Countries-2022 Supplier Shares and Strategies. 2022-2027 Volume and Sales Segment Forecasts for over 40 Individual Immunohematology and NAT Assays
US$ 18,500.00
January 2023
-
2020 Legionella Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
US$ 4,500.00
February 2020
203 pages
2024 Switzerland Endocrine Function Market for 20 Tests—2023 Supplier Shares and Strategies, Opportunities--2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline
US$ 1,450.00
January 2024
-
Agrochemicals: ADAMA, BASF, Bayer, Dow, DuPont, FMC, Monsanto, Nufarm, Sumitomo, Syngenta
US$ 2,800.00
June 2016
106 pages